Show simple item record

dc.contributor.authorSon, J.
dc.contributor.authorDu, W.
dc.contributor.authorEsposito, M.
dc.contributor.authorShariati, K.
dc.contributor.authorDing, H.
dc.contributor.authorKang, Y.
dc.contributor.authorAccili, D.
dc.date.accessioned2024-08-12T19:29:39Z
dc.date.available2024-08-12T19:29:39Z
dc.date.issued2023-02-02
dc.identifier.citationSon, J., Du, W., Esposito, M. et al. Genetic and pharmacologic inhibition of ALDH1A3 as a treatment of β-cell failure. Nat Commun 14, 558 (2023). https://doi.org/10.1038/s41467-023-36315-4
dc.identifier.issn2041-1723
dc.identifier.pmid36732513
dc.identifier.doi10.1038/s41467-023-36315-4
dc.identifier.urihttp://hdl.handle.net/10150/674193
dc.description.abstractType 2 diabetes (T2D) is associated with β-cell dedifferentiation. Aldehyde dehydrogenase 1 isoform A3 (ALHD1A3) is a marker of β-cell dedifferentiation and correlates with T2D progression. However, it is unknown whether ALDH1A3 activity contributes to β-cell failure, and whether the decrease of ALDH1A3-positive β-cells (A+) following pair-feeding of diabetic animals is due to β-cell restoration. To tackle these questions, we (i) investigated the fate of A+ cells during pair-feeding by lineage-tracing, (ii) somatically ablated ALDH1A3 in diabetic β-cells, and (iii) used a novel selective ALDH1A3 inhibitor to treat diabetes. Lineage tracing and functional characterization show that A+ cells can be reconverted to functional, mature β-cells. Genetic or pharmacological inhibition of ALDH1A3 in diabetic mice lowers glycemia and increases insulin secretion. Characterization of β-cells following ALDH1A3 inhibition shows reactivation of differentiation as well as regeneration pathways. We conclude that ALDH1A3 inhibition offers a therapeutic strategy against β-cell dysfunction in diabetes. © 2023, The Author(s).
dc.language.isoen
dc.publisherNature Research
dc.rights© The Author(s) 2023. This article is licensed under a Creative Commons Attribution 4.0 International License.
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleGenetic and pharmacologic inhibition of ALDH1A3 as a treatment of β-cell failure
dc.typeArticle
dc.typetext
dc.contributor.departmentDepartment of Pharmacy Practice & Science, College of Pharmacy, University of Arizona
dc.identifier.journalNature Communications
dc.description.noteOpen access journal
dc.description.collectioninformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.
dc.eprint.versionFinal Published Version
dc.source.journaltitleNature Communications
refterms.dateFOA2024-08-12T19:29:39Z


Files in this item

Thumbnail
Name:
s41467-023-36315-4.pdf
Size:
2.520Mb
Format:
PDF
Description:
Final Published Version

This item appears in the following Collection(s)

Show simple item record

© The Author(s) 2023. This article is licensed under a Creative Commons Attribution 4.0 International License.
Except where otherwise noted, this item's license is described as © The Author(s) 2023. This article is licensed under a Creative Commons Attribution 4.0 International License.